Cosmo Pharmaceuticals N.V. (CMOPF)

Market Cap	1.63B +70.1%
Revenue (ttm)	122.31M -61.0%
Net Income	-4.24M
EPS	-0.27
Shares Out	n/a
PE Ratio	n/a
Forward PE	873.45
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1
Average Volume	448
Open	102.31
Previous Close	102.93
Day's Range	102.31 - 102.31
52-Week Range	55.00 - 169.90
Beta	1.44
RSI	35.39
Earnings Date	Mar 9, 2026

About Cosmo Pharmaceuticals

Cosmo Pharmaceuticals N.V., a life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet approved to help get active, mild to moderate ulcerative colitis into remission; Uceris/Cor...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1997
• Employees: 325
• Stock Exchange: OTCMKTS
• Ticker Symbol: CMOPF

Financial Performance

Financial numbers in EUR